Increasing burden of treatment in the acute coronary syndromes: Is it justified?

Lancet

Volumn 361, Issue 9371, 2003, Pages 1813-1816

  Bogaty, Peter ^a   Brophy, James ^b  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; STATIN;

ANGIOPLASTY; CLINICAL PRACTICE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CORONARY STENT; DRUG TOLERABILITY; ECONOMIC ASPECT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HOSPITALIZATION; HUMAN; LONG TERM CARE; MEDICAL DECISION MAKING; META ANALYSIS; METHODOLOGY; MORTALITY; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; RESTENOSIS; REVIEW; ST SEGMENT ELEVATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0038101428     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)13407-1     Document Type: Note

References (26)

1. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med. 339:1998;436-443.
2. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med. 338:1998;1498-1505.
3. Simoons M.L. Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial. Lancet. 357:2001;1915-1924.
4. Ragmin F. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet. 354:1999;708-715.
5. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887.
6. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 345:2001;494-502.
7. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med. 338:1998;1488-1497.
8. Fox K.A.A., Poole-Wilson P.A., Henderson R.A., et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet. 360:2002;743-751.
9. Volpi A., De Vita C., Franzosi M.G., et al. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. Circulation. 88:1993;416-429.
10. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of Atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial. JAMA. 285:2001;1711-1718.
11. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 273:1995;408-412.
12. Erbel R., Haude M., Hopp H.W., et al. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med. 339:1998;1672-1678.
13. McPherson K., Britton A. Preferences and understanding their effects on health. Qual Health Care. 10:(suppl):2001;161-166.
14. Indications for ACE inhibitors in the early treatment of acute myocardial infarction systematic overview of individual data from 100 000 patients in randomized trials. Circulation. 97:1998;2202-2212.
15. Goodman S.N. Toward evidence-based medical statistics: 1 The P value fallacy. Ann Intern Med. 130:1999;995-1004.
16. Choudhry N.K., Stelfox H.T., Detsky A.S. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 287:2002;612-617.
17. Lewis H.D.J., Davis J.W., Archibald D.G., et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med. 309:1983;396-403.
18. Cairns J.A., Gent M., Singer J., et al. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial. N Engl J Med. 313:1985;1369-1375.
19. Effects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 342:2000;145-153.
20. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee on the management of patients with unstable angina). http://www.acc.org/clinical/guidelines/unstable/update_index.htm (accessed Oct 30, 2002).
21. Pfeffer M.A., Braunwald E., Moyé L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 327:1992;669-677.
22. Boersma E., Harrington R.A., Moliterno D.J., et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet. 359:2002;189-198.
23. Anderson H.V., Cannon C.P., Stone P.H., et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q-wave myocardial infarction. J Am Coll Cardiol. 26:1995;1643-1650.
24. Boden W.E., O'Rourke R.A., Crawford M.H., et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 338:1998;1785-1792.
25. Heidenreich P.A., Alloggiamento T., Melsop K., et al. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol. 38:2001;478-485.
26. Liem A.H., van Boven A.J., Zeeger N.J.G.M., et al. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial. Eur Heart J. 23:2002;1931-1937.